Zacks Investment Management Dexcom Inc Transaction History

Zacks Investment Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $583,766 - $807,890	-6,205 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$129.87 - $162.82 $160,129 - $200,757	1,233 Added 24.8%	6,205 $3.33 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $530,562 - $711,890	4,972 New	4,972 $2.72 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $432,768 - $534,592	-5,104 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $27,612 - $36,993	354 Added 7.45%	5,104 $1.89 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $84,335 - $99,734	883 Added 22.83%	4,750 $1.96 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $47,323 - $79,531	-755 Reduced 16.33%	3,867 $1.57 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $220,885 - $349,561	4,622 New	4,622 $1.24 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.